GE HealthCare Technologies Inc.
No SEC Form 4 filings for $GEHC in the last 30 days.
GE HealthCare introduced the LOGIQ e family, including LOGIQ e X1 and LOGIQ e S1, compact laptop ultrasound systems aimed at portable imaging across care settings. The systems add AI-powered workflow tools such as Scan Assistant and Voice Control, plus features like Nerveblox and MSK Go. GE says models are 510(k) cleared and CE marked, with availability in approved markets.
Argus Research raised its price target on GE HealthCare Technologies Inc. to $85 from $80, citing changes in its valuation, EPS revisions, and visibility metrics. The article also lists multiple composite rating frameworks (e.g., fundamentals, valuation, consensus, and ESG) used for its overall ratings.
Mizuho Securities analyst Anthony Petrone reiterated a Buy on GE Healthcare Technologies Inc (GEHC) on July 31 and set a $85.00 price target. The article also cites other analyst views, including a July 30 Buy from Stifel and a July 31 Hold from UBS. GEHC reported $5.3B quarterly revenue and $573M net profit for the quarter ended June 30.
Over the past 7 days, alphai's AI scored 9 news stories mentioning GEHC (GE HealthCare Technologies Inc.). Coverage has skewed bullish: 6 bullish, 2 neutral, and 1 bearish.
Recent GEHC coverage spans technology, financial news and market movers.
Product launch expands GEHC’s point-of-care ultrasound portfolio, potentially supporting incremental demand but with limited near-term financial signal.
PT raise suggests modestly improved analyst outlook, but the article provides no new company-specific operational or financial datapoint beyond the target change.
Street rating and price-target updates can move near-term sentiment, but the article provides no new operational or earnings catalyst.
Broad-based earnings outperformance suggests strong demand signals and supports continued upside into the next trading session.
The article provides fresh earnings datapoints plus management commentary on orders strength and PCS recovery, which can drive near-term positioning around guidance credibility.
alphai scores every news story that mentions GEHC with an AI model for sentiment and relevance, and aggregates insider trades from GE HealthCare Technologies Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
GE HealthCare introduced the LOGIQ e family, including LOGIQ e X1 and LOGIQ e S1, compact laptop ultrasound systems aimed at portable imaging across care settings. The systems add AI-powered workflow tools such as Scan Assistant and Voice Control, plus features like Nerveblox and MSK Go. GE says models are 510(k) cleared and CE marked, with availability in approved markets.
3 min readArgus Research raised its price target on GE HealthCare Technologies Inc. to $85 from $80, citing changes in its valuation, EPS revisions, and visibility metrics. The article also lists multiple composite rating frameworks (e.g., fundamentals, valuation, consensus, and ESG) used for its overall ratings.
2 min readMizuho Securities analyst Anthony Petrone reiterated a Buy on GE Healthcare Technologies Inc (GEHC) on July 31 and set a $85.00 price target. The article also cites other analyst views, including a July 30 Buy from Stifel and a July 31 Hold from UBS. GEHC reported $5.3B quarterly revenue and $573M net profit for the quarter ended June 30.
2 min readU.S. stock index futures rose slightly as Strait of Hormuz reopening talks were seen as progressing. Shopify shares jumped 26% after Q2 revenue of $3.58B beat $3.45B, with EPS $0.42 and gross merchandise volume up 32%. AMD shares fell 8.8% on a weaker revenue outlook. SpaceX said it will use Nvidia chips, pressuring AMD and wireless peers.
6 min readGE HealthCare reported Q2 revenue of $5.30B vs $5.27B estimates and adjusted EPS of $1.13 vs $1.04, with organic revenue up 3.5% and full-year adjusted EPS guidance reiterated at $4.90 (midpoint). Management cited strong orders growth, including Pharmaceutical Diagnostics and Advanced Imaging. Analysts asked about orders sustainability, Flyrcado ramp, PCS stabilization, inflation, and China dynamics.
6 min readIAM Union says GE HealthCare has delayed a first contract for about 130 IAM Local 1363 workers at its Aurora, Ohio MRI coil plant for over 18 months, alleging federal labor law violations. IAM sent letters to Ohio lawmakers and cites two NLRB unfair labor practice charges. IAM points to GE HealthCare’s $2B+ annual net income and says a July 2026 proposal was regressive.
4 min readGE HealthCare introduced the laptop-sized LOGIQ e ultrasound family, expanding its LOGIQ e platform. It includes LOGIQ e Xi with AI and workflow features and LOGIQ e Si with essential imaging at a lower price point. The systems support multiple clinical applications and include tools such as Scan Assistant, Voice Control, and Verisound fleet/cloud management. GE says the devices are 510(k) cleared and CE marked.
4 min readGE HealthCare said it launched Invenia ABUS Prime and ABUS StreamVue, citing U.S. FDA 510(k) clearance and CE Marking. The systems target supplemental breast ultrasound screening for dense breasts, with AI features and claims of faster scans and reduced reading time in studies. BeSound is among early U.S. installations. GE HealthCare is a $20.6B business.
3 min readGE HealthCare says it is expanding breast imaging for women with dense breasts by introducing Invenia ABUS Prime and launching ABUS StreamVue, a browser-based remote reading solution. The company cites 40% faster scanning, a 33% reduction in reading time, and up to 93% sensitivity for lesion detection. The products received 510(k) clearance and CE marking, according to GE HealthCare.
4 min readSep WTI crude oil prices (CLU26) jumped by more than +6% on Wednesday as the recent lull in hostilities came to an abrupt end after the Islamic Revolutionary Guard Corps (IRGC) said it targeted a US airbase and command center in Jordan with ballistic missiles. The IRGC also claimed to have hit and halted three tankers attempting to transit through the Strait of Hormuz.
7 min read
